Ulrik Mouritzen, Breye CEO

Oral al­ter­na­tive to eye in­jec­tions? No­vo backs start­up’s big plan to re­pur­pose shelved drug

For pa­tients with di­a­bet­ic retinopa­thy, an­ti-VEGF in­jec­tions to the eye are of­ten the on­ly non-sur­gi­cal op­tion to stave off vi­sion loss. But in re­cent years …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.